Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
When to see a doctor
Glucagon-like peptide-1 (GLP-1)-based agents (including GLP-1 analogues and dipeptidyl peptidase 4 inhibitors) have been recently approved as new therapeutic options for patients with type 2 diabetes, based upon the evidence that GLP-1 can stimulate glucose-dependent insulin secretion from pancreatic cells
The viniferin-treated group received 10 mg/kg/day for the first 38 days, then 25 mg/kg/day for the remaining 20 days of the 58-day study
SOURCE BodySpec
Aetna Student HealthSM is the brand name for products and services provided by Aetna Life Insurance Company and its affiliates (Aetna)
US$ 29.78
US$ 28.65
US$ 21.52
US$ 24.61
US$ 21.27
US$ 26.46
